Company intelligence / Profile preview

ARISE MD Integrative Medicine & Surgery

United States

Ownership: Private
Development stage: Other

Overview

Partnering with IncellDx’s Chronic COVID Treatment Center to conduct the first randomized, placebo-controlled trial evaluating CCR5 antagonists (maraviroc) and statins (atorvastatin) for alleviating PASC symptoms using an Enriched Enrollment Randomized Withdrawal design.[7]

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Academic Hospital/University/Research

Partnerships

IncellDx Chronic COVID Treatment Center

Beyond the preview

Go deeper on ARISE MD Integrative Medicine & Surgery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARISE MD Integrative Medicine & Surgery.

Explore the full profile